Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
- PMID: 32554533
- PMCID: PMC7301832
- DOI: 10.1183/13993003.01754-2020
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
Abstract
More than half of patients with COVID-19 pneumonia exhibit abnormal lung function 30 days after symptom onset, without clear relationship with pneumonia extent on chest CT. This pleads for systematic and long-term follow-up of patients with COVID-19.
Conflict of interest statement
Conflict of interest: J. Frija-Masson has nothing to disclose. Conflict of interest: M-P. Debray has nothing to disclose. Conflict of interest: M. Gilbert has nothing to disclose. Conflict of interest: F-X. Lescure reports personal fees for development of presentations from Gilead and MSD, and personal fees for travel/accommodation and meeting expenses from Astellas, Eumedica and MSD, outside the submitted work. Conflict of interest: F. Travert has nothing to disclose. Conflict of interest: R. Borie reports grants and personal fees from Roche, Boehringer Ingelheim and Savara, outside the submitted work. Conflict of interest: A. Khalil has nothing to disclose. Conflict of interest: B. Crestani has nothing to disclose. Conflict of interest: M-P. d'Ortho has nothing to disclose. Conflict of interest: C. Bancal has nothing to disclose.
Comment on
-
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.Eur Respir J. 2020 Jun 18;55(6):2001217. doi: 10.1183/13993003.01217-2020. Print 2020 Jun. Eur Respir J. 2020. PMID: 32381497 Free PMC article.
References
-
- European Respiratory Society. Recommendation from ERS Group 9.1 (Respiratory Function Technologists/Scientists). Lung Function Testing during COVID-19 Pandemic and Beyond https://ers.app.box.com/s/zs1uu88wy51monr0ewd990itoz4tsn2h Date last accessed 6 May, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous